Share Price and Basic Stock Data
Last Updated: February 13, 2026, 8:58 pm
| PEG Ratio | 0.00 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Kaya Ltd operates in the personal care industry, focusing on skincare and related services. As of September 2025, the company’s stock price stood at ₹335, with a market capitalization of ₹512 Cr. Over recent quarters, Kaya has experienced a significant decline in sales, with reported revenues of ₹100 Cr in December 2022, which fell to ₹51 Cr by September 2023. This downward trend continued into the following quarters, with sales recovering slightly to ₹54 Cr in December 2023. The trailing twelve months (TTM) revenue is reported at ₹219 Cr, indicating a challenging sales environment. The company’s operating profit margin (OPM) has consistently been negative, reflecting operational inefficiencies, with the most recent OPM recorded at -19%. This persistent decline in sales and profitability highlights the need for Kaya to reassess its market strategies and operational effectiveness to regain consumer confidence and market share.
Profitability and Efficiency Metrics
Kaya Ltd’s profitability metrics reveal a troubling trend, with net profit consistently in the negative territory. The net profit for the year ending March 2025 reported at -₹36 Cr, showcasing a significant deterioration from the previous year’s losses of -₹130 Cr. The company’s interest coverage ratio (ICR) stood at 1.14x, indicating that Kaya’s earnings barely cover its interest expenses, which is concerning for creditors and investors alike. The return on equity (ROE) remains at a precarious -60%, reflecting a severe inefficiency in utilizing shareholder funds to generate profits. The cash conversion cycle (CCC) reported at 283 days highlights inefficiencies in managing liquidity and working capital, suggesting that the company struggles to convert its sales into cash effectively. These profitability and efficiency metrics point to significant challenges that Kaya must address to stabilize its financial health.
Balance Sheet Strength and Financial Ratios
Kaya Ltd’s balance sheet reflects a precarious financial situation, with total borrowings reported at ₹278 Cr against reserves of -₹108 Cr. The company’s debt-to-equity ratio stood at -1.03, indicating that its liabilities exceed its equity, a concerning sign for investors. The book value per share, including revaluation reserves, is reported at -₹106.47, underscoring the company’s negative net worth. Additionally, the current ratio is at 0.46, which is below the typical sector benchmark of 1.0, indicating that Kaya may face difficulties meeting its short-term liabilities. The company’s asset turnover ratio of 0.81% suggests it is generating insufficient revenue from its asset base, further complicating its ability to improve profitability. These balance sheet indicators highlight significant financial distress, necessitating strategic actions to improve liquidity and solvency.
Shareholding Pattern and Investor Confidence
Kaya Ltd’s shareholding pattern indicates a dominant presence of promoters, holding 51.43% of the company as of September 2025. This is a decline from previous quarters where promoter holdings were higher, reflecting potential concerns about management’s ability to instill investor confidence amid ongoing financial difficulties. Foreign institutional investors (FIIs) have reduced their stake to 0.63%, while domestic institutional investors (DIIs) hold 2.53%. The public shareholding has increased to 45.40%, suggesting a shift in investor sentiment as retail investors may be absorbing shares from institutional players. The total number of shareholders has decreased to 18,724, indicating a potential loss of confidence from the investor community. This evolving shareholding structure may impact Kaya’s governance and strategic direction as it grapples with its financial challenges.
Outlook, Risks, and Final Insight
Kaya Ltd faces several challenges moving forward, primarily stemming from its declining sales and profitability. The company’s operational inefficiencies and high debt levels pose significant risks that could impede recovery. However, if Kaya successfully implements strategic initiatives to enhance operational efficiency and improve its product offerings, it may begin to stabilize its financial performance. The potential for recovery exists, particularly if management can leverage its brand and customer base effectively. Yet, the overarching risks of adverse market conditions and continued financial mismanagement could hinder progress. Ultimately, Kaya’s path to recovery hinges on decisive actions taken to rectify its operational and financial issues while restoring investor confidence in the long term.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Honasa Consumer Ltd | 9,808 Cr. | 301 | 334/190 | 63.5 | 38.8 | 0.00 % | 7.44 % | 5.51 % | 10.0 |
| Ambica Agarbathies Aroma & Industries Ltd | 42.3 Cr. | 24.6 | 33.0/22.3 | 61.2 | 65.2 | 0.00 % | 7.49 % | 0.45 % | 10.0 |
| Ador Multi Products Ltd | 109 Cr. | 114 | 149/23.4 | 32.5 | 0.00 % | 11.4 % | 3.09 % | 10.0 | |
| Kaya Ltd | 482 Cr. | 317 | 488/204 | 60.9 | 0.00 % | 2.50 % | % | 10.0 | |
| Jyothy Labs Ltd | 8,970 Cr. | 244 | 400/239 | 24.5 | 55.8 | 1.43 % | 24.6 % | 19.0 % | 1.00 |
| Industry Average | 69,140.86 Cr | 1,853.11 | 51.51 | 112.70 | 0.86% | 29.21% | 23.91% | 4.94 |
Quarterly Result
| Metric | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 100 | 93 | 60 | 51 | 54 | 52 | 52 | 53 | 58 | 55 | 53 | 54 | 60 |
| Expenses | 98 | 117 | 53 | 41 | 44 | 117 | 46 | 47 | 53 | 53 | 49 | 57 | 71 |
| Operating Profit | 2 | -25 | 6 | 10 | 11 | -65 | 6 | 6 | 5 | 2 | 4 | -3 | -11 |
| OPM % | 2% | -27% | 10% | 19% | 20% | -126% | 11% | 11% | 8% | 3% | 7% | -6% | -19% |
| Other Income | 2 | 1 | -1 | -6 | -4 | -18 | 113 | -4 | 16 | 9 | 1 | 4 | -4 |
| Interest | 6 | 17 | 6 | 6 | 7 | 7 | 7 | 8 | 8 | 8 | 8 | 9 | 9 |
| Depreciation | 15 | 16 | 10 | 9 | 9 | 9 | 9 | 9 | 10 | 9 | 10 | 11 | 12 |
| Profit before tax | -18 | -56 | -10 | -12 | -9 | -99 | 103 | -16 | 4 | -7 | -14 | -19 | -36 |
| Tax % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Profit | -18 | -56 | -10 | -12 | -9 | -99 | 103 | -16 | 4 | -7 | -14 | -19 | -36 |
| EPS in Rs | -13.62 | -43.15 | -7.88 | -8.91 | -6.86 | -75.96 | 78.61 | -11.96 | 2.81 | -5.36 | -10.76 | -12.35 | -23.41 |
Last Updated: February 5, 2026, 8:02 am
Below is a detailed analysis of the quarterly data for Kaya Ltd based on the most recent figures (Dec 2025) and their trends compared to the previous period:
- For Sales, as of Dec 2025, the value is 60.00 Cr.. The value appears strong and on an upward trend. It has increased from 54.00 Cr. (Sep 2025) to 60.00 Cr., marking an increase of 6.00 Cr..
- For Expenses, as of Dec 2025, the value is 71.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 57.00 Cr. (Sep 2025) to 71.00 Cr., marking an increase of 14.00 Cr..
- For Operating Profit, as of Dec 2025, the value is -11.00 Cr.. The value appears to be declining and may need further review. It has decreased from -3.00 Cr. (Sep 2025) to -11.00 Cr., marking a decrease of 8.00 Cr..
- For OPM %, as of Dec 2025, the value is -19.00%. The value appears to be declining and may need further review. It has decreased from -6.00% (Sep 2025) to -19.00%, marking a decrease of 13.00%.
- For Other Income, as of Dec 2025, the value is -4.00 Cr.. The value appears to be declining and may need further review. It has decreased from 4.00 Cr. (Sep 2025) to -4.00 Cr., marking a decrease of 8.00 Cr..
- For Interest, as of Dec 2025, the value is 9.00 Cr.. The value remains steady. There is no change compared to the previous period (Sep 2025) which recorded 9.00 Cr..
- For Depreciation, as of Dec 2025, the value is 12.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 11.00 Cr. (Sep 2025) to 12.00 Cr., marking an increase of 1.00 Cr..
- For Profit before tax, as of Dec 2025, the value is -36.00 Cr.. The value appears to be declining and may need further review. It has decreased from -19.00 Cr. (Sep 2025) to -36.00 Cr., marking a decrease of 17.00 Cr..
- For Tax %, as of Dec 2025, the value is 0.00%. The value remains steady. There is no change compared to the previous period (Sep 2025) which recorded 0.00%.
- For Net Profit, as of Dec 2025, the value is -36.00 Cr.. The value appears to be declining and may need further review. It has decreased from -19.00 Cr. (Sep 2025) to -36.00 Cr., marking a decrease of 17.00 Cr..
- For EPS in Rs, as of Dec 2025, the value is -23.41. The value appears to be declining and may need further review. It has decreased from -12.35 (Sep 2025) to -23.41, marking a decrease of 11.06.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 5:06 am
| Metric | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 332 | 370 | 409 | 400 | 421 | 393 | 275 | 324 | 377 | 205 | 217 | 219 |
| Expenses | 296 | 352 | 425 | 399 | 408 | 338 | 248 | 305 | 395 | 241 | 198 | 213 |
| Operating Profit | 37 | 18 | -16 | 1 | 13 | 56 | 27 | 19 | -19 | -36 | 20 | 7 |
| OPM % | 11% | 5% | -4% | 0% | 3% | 14% | 10% | 6% | -5% | -17% | 9% | 3% |
| Other Income | 11 | 12 | 10 | 9 | 4 | 9 | 15 | 12 | 5 | -31 | 134 | 30 |
| Interest | 4 | 4 | 5 | 7 | 9 | 22 | 19 | 21 | 42 | 27 | 32 | 33 |
| Depreciation | 12 | 17 | 20 | 24 | 29 | 75 | 60 | 78 | 61 | 35 | 38 | 40 |
| Profit before tax | 32 | 9 | -31 | -20 | -21 | -33 | -37 | -68 | -116 | -130 | 84 | -36 |
| Tax % | 0% | 0% | -8% | -2% | -26% | 64% | 0% | 0% | 0% | 0% | 0% | |
| Net Profit | 32 | 9 | -28 | -20 | -16 | -54 | -37 | -68 | -116 | -130 | 84 | -36 |
| EPS in Rs | 6.82 | -22.23 | -16.22 | -12.22 | -41.66 | -29.10 | -52.69 | -89.15 | -98.91 | 63.89 | -25.66 | |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
YoY Net Profit Growth
| Year | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -71.88% | -411.11% | 28.57% | 20.00% | -237.50% | 31.48% | -83.78% | -70.59% | -12.07% | 164.62% |
| Change in YoY Net Profit Growth (%) | 0.00% | -339.24% | 439.68% | -8.57% | -257.50% | 268.98% | -115.27% | 13.20% | 58.52% | 176.68% |
Kaya Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 10 years from 2015-2016 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | -4% |
| 5 Years: | -11% |
| 3 Years: | -12% |
| TTM: | 4% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 14% |
| 5 Years: | 28% |
| 3 Years: | 47% |
| TTM: | 46% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | -9% |
| 5 Years: | 13% |
| 3 Years: | 7% |
| 1 Year: | -16% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | % |
Last Updated: September 5, 2025, 8:55 am
Balance Sheet
Last Updated: December 4, 2025, 1:31 am
| Month | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 0.00 | 13 | 13 | 13 | 13 | 13 | 13 | 13 | 13 | 13 | 13 | 15 |
| Reserves | 222 | 238 | 216 | 197 | 145 | 69 | 41 | -15 | -117 | -240 | -153 | -108 |
| Borrowings | 0 | 0 | 30 | 25 | 35 | 167 | 160 | 204 | 249 | 301 | 256 | 278 |
| Other Liabilities | 151 | 155 | 187 | 136 | 176 | 160 | 153 | 159 | 225 | 221 | 120 | 123 |
| Total Liabilities | 373 | 407 | 445 | 372 | 368 | 409 | 368 | 361 | 370 | 295 | 237 | 308 |
| Fixed Assets | 112 | 149 | 193 | 201 | 206 | 303 | 279 | 240 | 217 | 174 | 158 | 184 |
| CWIP | 3 | 2 | 2 | 1 | 1 | 1 | 1 | 2 | 2 | 1 | 1 | 0 |
| Investments | 152 | 88 | 72 | 20 | 14 | 19 | 11 | 26 | 21 | 29 | 4 | 58 |
| Other Assets | 105 | 167 | 179 | 149 | 147 | 86 | 77 | 93 | 130 | 91 | 74 | 66 |
| Total Assets | 373 | 407 | 445 | 372 | 368 | 409 | 368 | 361 | 370 | 295 | 237 | 308 |
Below is a detailed analysis of the balance sheet data for Kaya Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 15.00 Cr.. The value appears strong and on an upward trend. It has increased from 13.00 Cr. (Mar 2025) to 15.00 Cr., marking an increase of 2.00 Cr..
- For Reserves, as of Sep 2025, the value is -108.00 Cr.. The value appears to be improving (becoming less negative). It has improved from -153.00 Cr. (Mar 2025) to -108.00 Cr., marking an improvement of 45.00 Cr..
- For Borrowings, as of Sep 2025, the value is 278.00 Cr.. The value appears to be increasing, which may not be favorable. However, Reserves are negative, which is a major warning sign. It has increased from 256.00 Cr. (Mar 2025) to 278.00 Cr., marking an increase of 22.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 123.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 120.00 Cr. (Mar 2025) to 123.00 Cr., marking an increase of 3.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 308.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 237.00 Cr. (Mar 2025) to 308.00 Cr., marking an increase of 71.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 184.00 Cr.. The value appears strong and on an upward trend. It has increased from 158.00 Cr. (Mar 2025) to 184.00 Cr., marking an increase of 26.00 Cr..
- For CWIP, as of Sep 2025, the value is 0.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1.00 Cr. (Mar 2025) to 0.00 Cr., marking a decrease of 1.00 Cr..
- For Investments, as of Sep 2025, the value is 58.00 Cr.. The value appears strong and on an upward trend. It has increased from 4.00 Cr. (Mar 2025) to 58.00 Cr., marking an increase of 54.00 Cr..
- For Other Assets, as of Sep 2025, the value is 66.00 Cr.. The value appears to be declining and may need further review. It has decreased from 74.00 Cr. (Mar 2025) to 66.00 Cr., marking a decrease of 8.00 Cr..
- For Total Assets, as of Sep 2025, the value is 308.00 Cr.. The value appears strong and on an upward trend. It has increased from 237.00 Cr. (Mar 2025) to 308.00 Cr., marking an increase of 71.00 Cr..
However, the Borrowings (278.00 Cr.) are higher than the Reserves (-108.00 Cr.), which may signal higher financial risk.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 37.00 | 18.00 | -46.00 | -24.00 | -22.00 | -111.00 | -133.00 | -185.00 | -268.00 | -337.00 | -236.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 0 | 1 | 2 | 3 | 5 | 5 | 4 | 4 | 3 | 7 | 4 |
| Inventory Days | 419 | 492 | 493 | 746 | 614 | ||||||
| Days Payable | 360 | 349 | 339 | 1,303 | 335 | ||||||
| Cash Conversion Cycle | 60 | 144 | 156 | 3 | 5 | 5 | 4 | 4 | 3 | -550 | 283 |
| Working Capital Days | -80 | -27 | -81 | -52 | -86 | -112 | -170 | -160 | -175 | -408 | -147 |
| ROCE % | 2% | -12% | -7% | -6% | -5% | -8% | -23% | -44% | -62% | -2% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 63.95 | -98.91 | -89.15 | -52.69 | -29.10 |
| Diluted EPS (Rs.) | 63.94 | -98.91 | -89.15 | -52.69 | -29.10 |
| Cash EPS (Rs.) | 92.63 | -50.23 | -42.97 | 13.75 | 17.40 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | -106.47 | -173.60 | -78.89 | -0.78 | 41.99 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | -106.47 | -173.60 | -78.89 | -0.78 | 41.99 |
| Revenue From Operations / Share (Rs.) | 165.81 | 309.44 | 288.37 | 247.98 | 210.47 |
| PBDIT / Share (Rs.) | 26.67 | -23.03 | -15.49 | 25.74 | 28.73 |
| PBIT / Share (Rs.) | -2.07 | -71.27 | -61.51 | -40.04 | -17.31 |
| PBT / Share (Rs.) | -25.48 | -98.48 | -88.99 | -52.02 | -28.64 |
| Net Profit / Share (Rs.) | 63.89 | -98.48 | -88.99 | -52.02 | -28.64 |
| NP After MI And SOA / Share (Rs.) | 63.89 | -98.91 | -89.15 | -52.69 | -29.10 |
| PBDIT Margin (%) | 16.08 | -7.44 | -5.37 | 10.37 | 13.64 |
| PBIT Margin (%) | -1.24 | -23.03 | -21.33 | -16.14 | -8.22 |
| PBT Margin (%) | -15.36 | -31.82 | -30.86 | -20.97 | -13.60 |
| Net Profit Margin (%) | 38.53 | -31.82 | -30.86 | -20.97 | -13.60 |
| NP After MI And SOA Margin (%) | 38.53 | -31.96 | -30.91 | -21.24 | -13.82 |
| Return on Networth / Equity (%) | -60.00 | 0.00 | 0.00 | 0.00 | -69.77 |
| Return on Capital Employeed (%) | -2.85 | -984.70 | -66.23 | -31.65 | -12.13 |
| Return On Assets (%) | 35.34 | -43.73 | -31.48 | -19.06 | -10.32 |
| Long Term Debt / Equity (X) | -1.03 | -0.62 | -1.37 | -50.57 | 0.52 |
| Total Debt / Equity (X) | -1.03 | -0.78 | -1.37 | -55.43 | 0.52 |
| Asset Turnover Ratio (%) | 0.81 | 1.22 | 0.53 | 0.40 | 0.34 |
| Current Ratio (X) | 0.46 | 0.35 | 0.57 | 0.53 | 0.42 |
| Quick Ratio (X) | 0.28 | 0.25 | 0.45 | 0.40 | 0.27 |
| Inventory Turnover Ratio (X) | 7.99 | 0.30 | 0.36 | 0.37 | 0.24 |
| Interest Coverage Ratio (X) | 1.14 | -0.84 | -0.56 | 2.15 | 2.54 |
| Interest Coverage Ratio (Post Tax) (X) | -0.08 | -2.62 | -2.24 | -3.34 | -1.53 |
| Enterprise Value (Cr.) | 442.38 | 569.38 | 419.64 | 518.54 | 403.30 |
| EV / Net Operating Revenue (X) | 2.04 | 1.41 | 1.11 | 1.60 | 1.47 |
| EV / EBITDA (X) | 12.66 | -18.93 | -20.74 | 15.42 | 10.75 |
| MarketCap / Net Operating Revenue (X) | 1.41 | 1.01 | 0.87 | 1.41 | 1.41 |
| Price / BV (X) | -2.19 | -1.81 | -3.19 | -294.70 | 7.11 |
| Price / Net Operating Revenue (X) | 1.41 | 1.01 | 0.87 | 1.41 | 1.41 |
| EarningsYield | 0.27 | -0.31 | -0.35 | -0.15 | -0.09 |
After reviewing the key financial ratios for Kaya Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 63.95. This value is within the healthy range. It has increased from -98.91 (Mar 24) to 63.95, marking an increase of 162.86.
- For Diluted EPS (Rs.), as of Mar 25, the value is 63.94. This value is within the healthy range. It has increased from -98.91 (Mar 24) to 63.94, marking an increase of 162.85.
- For Cash EPS (Rs.), as of Mar 25, the value is 92.63. This value is within the healthy range. It has increased from -50.23 (Mar 24) to 92.63, marking an increase of 142.86.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is -106.47. It has increased from -173.60 (Mar 24) to -106.47, marking an increase of 67.13.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is -106.47. It has increased from -173.60 (Mar 24) to -106.47, marking an increase of 67.13.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 165.81. It has decreased from 309.44 (Mar 24) to 165.81, marking a decrease of 143.63.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 26.67. This value is within the healthy range. It has increased from -23.03 (Mar 24) to 26.67, marking an increase of 49.70.
- For PBIT / Share (Rs.), as of Mar 25, the value is -2.07. This value is below the healthy minimum of 0. It has increased from -71.27 (Mar 24) to -2.07, marking an increase of 69.20.
- For PBT / Share (Rs.), as of Mar 25, the value is -25.48. This value is below the healthy minimum of 0. It has increased from -98.48 (Mar 24) to -25.48, marking an increase of 73.00.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 63.89. This value is within the healthy range. It has increased from -98.48 (Mar 24) to 63.89, marking an increase of 162.37.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 63.89. This value is within the healthy range. It has increased from -98.91 (Mar 24) to 63.89, marking an increase of 162.80.
- For PBDIT Margin (%), as of Mar 25, the value is 16.08. This value is within the healthy range. It has increased from -7.44 (Mar 24) to 16.08, marking an increase of 23.52.
- For PBIT Margin (%), as of Mar 25, the value is -1.24. This value is below the healthy minimum of 10. It has increased from -23.03 (Mar 24) to -1.24, marking an increase of 21.79.
- For PBT Margin (%), as of Mar 25, the value is -15.36. This value is below the healthy minimum of 10. It has increased from -31.82 (Mar 24) to -15.36, marking an increase of 16.46.
- For Net Profit Margin (%), as of Mar 25, the value is 38.53. This value exceeds the healthy maximum of 10. It has increased from -31.82 (Mar 24) to 38.53, marking an increase of 70.35.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 38.53. This value exceeds the healthy maximum of 20. It has increased from -31.96 (Mar 24) to 38.53, marking an increase of 70.49.
- For Return on Networth / Equity (%), as of Mar 25, the value is -60.00. This value is below the healthy minimum of 15. It has decreased from 0.00 (Mar 24) to -60.00, marking a decrease of 60.00.
- For Return on Capital Employeed (%), as of Mar 25, the value is -2.85. This value is below the healthy minimum of 10. It has increased from -984.70 (Mar 24) to -2.85, marking an increase of 981.85.
- For Return On Assets (%), as of Mar 25, the value is 35.34. This value is within the healthy range. It has increased from -43.73 (Mar 24) to 35.34, marking an increase of 79.07.
- For Long Term Debt / Equity (X), as of Mar 25, the value is -1.03. This value is below the healthy minimum of 0.2. It has decreased from -0.62 (Mar 24) to -1.03, marking a decrease of 0.41.
- For Total Debt / Equity (X), as of Mar 25, the value is -1.03. This value is within the healthy range. It has decreased from -0.78 (Mar 24) to -1.03, marking a decrease of 0.25.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.81. It has decreased from 1.22 (Mar 24) to 0.81, marking a decrease of 0.41.
- For Current Ratio (X), as of Mar 25, the value is 0.46. This value is below the healthy minimum of 1.5. It has increased from 0.35 (Mar 24) to 0.46, marking an increase of 0.11.
- For Quick Ratio (X), as of Mar 25, the value is 0.28. This value is below the healthy minimum of 1. It has increased from 0.25 (Mar 24) to 0.28, marking an increase of 0.03.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 7.99. This value is within the healthy range. It has increased from 0.30 (Mar 24) to 7.99, marking an increase of 7.69.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 1.14. This value is below the healthy minimum of 3. It has increased from -0.84 (Mar 24) to 1.14, marking an increase of 1.98.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is -0.08. This value is below the healthy minimum of 3. It has increased from -2.62 (Mar 24) to -0.08, marking an increase of 2.54.
- For Enterprise Value (Cr.), as of Mar 25, the value is 442.38. It has decreased from 569.38 (Mar 24) to 442.38, marking a decrease of 127.00.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 2.04. This value is within the healthy range. It has increased from 1.41 (Mar 24) to 2.04, marking an increase of 0.63.
- For EV / EBITDA (X), as of Mar 25, the value is 12.66. This value is within the healthy range. It has increased from -18.93 (Mar 24) to 12.66, marking an increase of 31.59.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.41. This value is within the healthy range. It has increased from 1.01 (Mar 24) to 1.41, marking an increase of 0.40.
- For Price / BV (X), as of Mar 25, the value is -2.19. This value is below the healthy minimum of 1. It has decreased from -1.81 (Mar 24) to -2.19, marking a decrease of 0.38.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.41. This value is within the healthy range. It has increased from 1.01 (Mar 24) to 1.41, marking an increase of 0.40.
- For EarningsYield, as of Mar 25, the value is 0.27. This value is below the healthy minimum of 5. It has increased from -0.31 (Mar 24) to 0.27, marking an increase of 0.58.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Kaya Ltd:
- Net Profit Margin: 38.53%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: -2.85% (Industry Average ROCE: 29.21%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: -60% (Industry Average ROE: 23.91%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): -0.08
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.28
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 0 (Industry average Stock P/E: 51.51)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: -1.03
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 38.53%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Personal Care | 23/C, Mahal Industrial Area, Mahakali Caves Road, Mumbai Maharashtra 400093 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Harsh Mariwala | Chairman & Managing Director |
| Mr. Rajendra Mariwala | Non Exe.Non Ind.Director |
| Mr. Rishabh Mariwala | Non Exe.Non Ind.Director |
| Mr. Nikhil Khattau | Non Exe.Non Ind.Director |
| Mr. Vivek Karve | Ind. Non-Executive Director |
| Ms. Anita Belani | Ind. Non-Executive Director |
| Ms. Vasuta Agarwal | Ind. Non-Executive Director |
| Dr. Om Manchanda | Ind. Non-Executive Director |
FAQ
What is the intrinsic value of Kaya Ltd?
Kaya Ltd's intrinsic value (as of 14 February 2026) is ₹217.77 which is 31.30% lower the current market price of ₹317.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹482 Cr. market cap, FY2025-2026 high/low of ₹488/204, reserves of ₹-108 Cr, and liabilities of ₹308 Cr.
What is the Market Cap of Kaya Ltd?
The Market Cap of Kaya Ltd is 482 Cr..
What is the current Stock Price of Kaya Ltd as on 14 February 2026?
The current stock price of Kaya Ltd as on 14 February 2026 is ₹317.
What is the High / Low of Kaya Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Kaya Ltd stocks is ₹488/204.
What is the Stock P/E of Kaya Ltd?
The Stock P/E of Kaya Ltd is .
What is the Book Value of Kaya Ltd?
The Book Value of Kaya Ltd is 60.9.
What is the Dividend Yield of Kaya Ltd?
The Dividend Yield of Kaya Ltd is 0.00 %.
What is the ROCE of Kaya Ltd?
The ROCE of Kaya Ltd is 2.50 %.
What is the ROE of Kaya Ltd?
The ROE of Kaya Ltd is %.
What is the Face Value of Kaya Ltd?
The Face Value of Kaya Ltd is 10.0.